Clinical Trial Update: Reduction of C-Difficile Infection Using Stool Transplant [Phase 1]

View source ↗

Summary

Phase 1 trial investigating fecal microbiota transplantation to reduce Clostridioides difficile infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clostridioides Difficile Infection

Drugs mentioned

• Fecal microbiota transplantation (fecal microbiota transplantation)

Snippet

Sponsor: Providence Holy Cross Medical Center | Conditions: C-difficile | Phase 1 | Status: UNKNOWN